Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue BMC Infectious Diseases Année : 2020

Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report

Résumé

BACKGROUND: Yellow fever vaccine exists for over 80 years and is considered to be relatively safe. However, in rare cases it can produce serious neurotropic and viscerotropic complications. We report a case of a patient who presented both viscerotropic and neurological manifestations after yellow fever vaccination. CASE PRESENTATION: We describe the case of a 37 years old man who developed after the yellow fever vaccination a yellow fever vaccine-associated viscerotropic disease followed by acute uveitis. Prolonged detection of yellow fever RNA in blood and urine was consistent with yellow fever vaccine-associated adverse event. The final outcome was good, although with persistent fatigue over a few months. CONCLUSIONS: Even if the yellow fever vaccine is relatively safe, physicians should be aware of its possible serious adverse effects.
Fichier principal
Vignette du fichier
Volkov2020_Article_ViscerotropicDiseaseAndAcuteUv.pdf (843.71 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

inserm-02513378 , version 1 (20-03-2020)

Identifiants

Citer

Lev Volkov, Gilda Grard, Pierre-Edouard Bollaert, Guillaume A Durand, Aurélie Cravoisy, et al.. Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report. BMC Infectious Diseases, 2020, 20 (1), pp.116. ⟨10.1186/s12879-020-4838-x⟩. ⟨inserm-02513378⟩
125 Consultations
58 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More